Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

MedMira Granted China Patent for Diagnostic Device

publication date: Jul 22, 2008

MedMira Inc., a Canadian company, received a China patent for its rapid diagnostic device and assay (Chinese Patent Application No. 02819646.5). The patents covers the rapid flow-through technology (RFT) platform on which the company has built its line of 3-minute tests for HIV, hepatitis and other diseases. MedMira says it is continuing to seek partners to further its growth as a company. These initiatives include seeking companies who want to build new rapid tests on MedMira’s RFT platform. More details...

Stock Symbols: (TSX Venture: MIR) (NSDQ: MMIRF)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital